The Covid sales boom is over for Pfizer
By Paul R. La Monica
Pfizer expects 2023 sales to decline as much as 33% compared with record-breaking 2022
By Spencer Kimball
Pfizer sees steep 2023 fall in COVID sales, aims to bolster pipeline
By Michael Erman & Bhanvi Satija
Pfizer sees COVID-19 product sales plummeting in 2023
By Kevin Dunleavy